Centauri Therapeutics
Developing novel Alphamer® therapeutics to combat serious diseases, with a primary focus on antimicrobial resistance (AMR).
About
Centauri Therapeutics is a biotechnology company based in Alderley Park, UK, focused on the discovery and development of novel therapeutics for serious diseases. Leveraging its proprietary Alphamer® platform, the company develops immunotherapies that harness the body's natural immune response to fight life-threatening infections, particularly multi-drug resistant Gram-negative bacteria. The platform also has initial proof-of-concept data in oncology, expanding therapeutic options for vulnerable patients. Teams look it up for Biotechnology, Pharmaceuticals, Drug Discovery.
Frequently asked
What does Centauri Therapeutics do?
Centauri Therapeutics is a Biotechnology company that offers Platform. Teams look it up for Pharmaceuticals, Drug Discovery, Antimicrobial Resistance. It is based in Oxford, England, United Kingdom and was founded in 2013. Public records show $57M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Centauri Therapeutics raised?
Centauri Therapeutics has raised a total of $57M in funding. The most recent round on record is Series A.
Where is Centauri Therapeutics headquartered?
Centauri Therapeutics is headquartered in Oxford, England, United Kingdom.
When was Centauri Therapeutics founded?
Centauri Therapeutics was founded in 2013.
What industry does Centauri Therapeutics operate in?
Centauri Therapeutics operates in Biotechnology, Pharmaceuticals, Drug Discovery, Antimicrobial Resistance.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.